Clinical Trial Update: Letrozole in the Treatment of 1st and 2nd Line Hormone Receptor Positive Breast Cancer: Pre-therapeutic Risk Assessment [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating letrozole for first- and second-line hormone receptor–positive metastatic breast cancer has been terminated, with updates on pre-therap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Metastatic Breast Cancer | Phase 4 | Status: TERMINATED